Login
Related Links
Gene Therapy Research Institutes - Europe
- Finland - A.I. Virtanen Institute of Molecular Medicine, University of Kuopio
- Finland - Cancer Gene Therapy Group, University of Helsinki
- Israel - The Goldyne Savad Institiute of Gene Therapy, Hadassah, Jerusalem
- Italy - San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan
- Italy - TIGEM - Telethon Institute of Genetics and Medicine, Napoli
- Netherlands - Oncogenomics VUmc, Amsterdam
- Netherlands - Pharmaceutical Gene Modulation, Groningen
- Spain - Viral Vector Production Unit (UPV), Universitat Autonoma de Barcelona
- Sweden - Molecular Medicine and Gene Therapy, Lund University
- Turkey - Human Gene and Cell Therapy Center, Akdeniz University Hospitals and Clinics
The research is on cardiovascular, neurodegenerative, and metabolism-related diseases. Main target genes are vascular growth factors, and LDL receptor in cardiovascular area and cytotoxic genes in cancer therapy.
The group of Akseli Hemminki uses gene therapy and oncolytic viruses to improve the treatment of cancers lacking currently available effective modalities.
Research covers a wide range of diseases along three main tracks: cellular gene therapy, viral vectors and non-viral vectors. The Institute is headed by Prof. Eithan Galun, M.D.
The group headed by Luigi Naldini performs basic research on gene transfer technologies and new gene therapy strategies for immunodeficiencies, lysosomal storage disorders, thalassemia, hemofilia B.
The interest of group of Alberto Auricchio is to use Adeno-Associated Virus (AAV)-mediated gene transfer as potential therapy for ocular and metabolic diseases
The Gene Therapy research group aims to design new anti-cancer therapies using oncolytic adenoviruses and modulation of gene expression, with particular attention to the p53 tumor suppressor pathway.
The department is headed by Prof. Hidde Haisma and is focused on the development of drugs for the therapeutic manipulation of gene activity. The research is focused on cancer and inflammatory diseases.
UPV is a vector core specialized in the cloning, production and purification of adenovirus (human and canine) and adeno-associated virus (AAV) serotypes for public institutions and private companies all over the world.
The laboratory investigates the properties of blood stem cells and is developing cell and gene therapy for blood disorders: Diamond-Blackfan Anemia and Gaucher Disease.
The laboratory is headed by Prof. Dr. Salih Sanlioglu and his team are involved in the development of novel gene therapy methods for patients with type 2 diabetes using lentiviral vectors.
Info Research Centers
Overview of research institutes, centers and universities involved in pre-clinical and clinical gene therapy research:
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
US & Canada | |
Europe | |
Australia |
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
Gene Therapy News
- Gene therapy improves or reverses age-related disease in mice - McKnight's Long-Term Care News
Sat, 20 Apr 2024 02:53:0 GMT - Ferring takes steps to ensure long term supply of gene therapy - The Pharma Letter
Sat, 20 Apr 2024 01:41:4 GMT - Cell and gene therapy approach shows promise for EB children - Epidermolysis Bullosa News
Fri, 19 Apr 2024 20:49:0 GMT - Q&A: Cell and gene therapy value assessments need a rework to allow access - Pharmaceutical Technology
Fri, 19 Apr 2024 18:05:1 GMT - Ocugen completes dosing in latest dry AMD gene therapy trial - Investing.com India
Fri, 19 Apr 2024 17:46:5 GMT - Do P&T Committees Need Help With Cell and Gene Therapy? | AMCP 2024 - Managed Healthcare Executive
Fri, 19 Apr 2024 16:17:3 GMT - AskBio's AB-1002 gene therapy receives FDA fast-track status - Pharmaceutical Technology
Fri, 19 Apr 2024 12:23:2 GMT - New gene therapy platform is helping transform lives - Spectrum News 1
Fri, 19 Apr 2024 12:15:0 GMT - Long Island boy with rare blood disorder undergoes gene therapy - PIX11 New York News
Fri, 19 Apr 2024 01:39:1 GMT - New gene therapy eliminates need for bone marrow transplant. Here's how it works. - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Long Island boy undergoes groundbreaking gene therapy - CBS New York - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Boy with rare blood disorder receives new life-changing gene therapy treatment - FOX 5 New York
Thu, 18 Apr 2024 23:52:2 GMT - Gene Therapy Stops Cancer: Will It Tackle Brain Tumors? - Mirage News
Thu, 18 Apr 2024 23:32:0 GMT - Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV
Thu, 18 Apr 2024 22:56:0 GMT - Hospital gives first dose of gene therapy for DMD in WV - WDTV
Thu, 18 Apr 2024 21:47:0 GMT